Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Operating Expenses: 2020-2024

Historic Operating Expenses for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to -$98.6 million.

  • Burning Rock Biotech's Operating Expenses rose 20.73% to -$16.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$69.2 million, marking a year-over-year increase of 40.11%. This contributed to the annual value of -$98.6 million for FY2024, which is 32.18% up from last year.
  • As of FY2024, Burning Rock Biotech's Operating Expenses stood at -$98.6 million, which was up 32.18% from -$145.4 million recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's Operating Expenses registered a high of -$98.6 million during FY2024, and its lowest value of -$197.2 million during FY2022.
  • In the last 3 years, Burning Rock Biotech's Operating Expenses had a median value of -$145.4 million in 2023 and averaged -$147.1 million.
  • In the last 5 years, Burning Rock Biotech's Operating Expenses tumbled by 63.70% in 2021 and then skyrocketed by 32.18% in 2024.
  • Over the past 5 years, Burning Rock Biotech's Operating Expenses (MRY) stood at -$111.3 million in 2020, then crashed by 63.70% to -$182.2 million in 2021, then fell by 8.25% to -$197.2 million in 2022, then rose by 26.27% to -$145.4 million in 2023, then soared by 32.18% to -$98.6 million in 2024.
  • Its Operating Expenses stands at -$98.6 million for FY2024, versus -$145.4 million for FY2023 and -$197.2 million for FY2022.